Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Type-2 Diabetes Prevention in Women with a Recent History of Gestational Diabetes Mellitus, Potential Extramural Project (PEP) 2008-R-04, 34023-34024 [E8-13493]

Download as PDF Federal Register / Vol. 73, No. 116 / Monday, June 16, 2008 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Evaluation of Breastfeeding Promotion and Support Programs for African-American Women, Potential Extramural Project 2008–R–25 Correction: This notice was published in the Federal Register on April 18, 2008, Volume 73, Number 76, page 21138. The aforementioned meeting has been rescheduled to the following: Time and Date: 1:00 p.m.–3:00 p.m., June 19, 2008 (Closed). Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road NE., Mailstop E21, Atlanta, GA 30333. Telephone (404) 498–1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 9, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–13472 Filed 6–13–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention rwilkins on PROD1PC63 with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Promoting Awareness of Birth Defects Prevention, Potential Extramural Project 2008–R–14 Correction: This notice was published in the Federal Register on April 16, 2008, Volume 73, Number 74, page 20679. The aforementioned meeting has been rescheduled to the following: Time and Date: 1 p.m.–3 p.m., June 19, 2008 (Closed). Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., VerDate Aug<31>2005 18:44 Jun 13, 2008 Jkt 214001 Mailstop E21, Atlanta, GA 30333. Telephone (404) 498–1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 9, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–13488 Filed 6–13–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Improving Postpartum Follow up in Women With a Gestational Diabetes-Affected Pregnancy, Potential Extramural Project (PEP) 2008–R–02 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time And Date: 1 p.m.–3 p.m., June 18, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. This notice was published in the Federal Register on April 16, 2008, Volume 73, Number 74, page 20677. Additional time is required to complete the review of all applications submitted for this PEP. Applications being reviewed at the June 18, 2008, meeting will be reviewed by the same members of the original panel. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Improving Postpartum Follow up in Women with a Gestational DiabetesAffected Pregnancy, PEP 2008–R–02.’’ The National Center for Health Marketing determines that agency business requires its consideration of this matter on less than 15 days’ notice to the public and that no earlier notice of this meeting was possible. Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333, Telephone (404) 498– 1194. PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 34023 The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 9, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–13491 Filed 6–13–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Type-2 Diabetes Prevention in Women with a Recent History of Gestational Diabetes Mellitus, Potential Extramural Project (PEP) 2008–R–04 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 1 p.m.–4 p.m., June 18, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. This notice was published in the Federal Register on April 17, 2008, Volume 73, Number 75, page 20927. Additional time is required to complete the review of all applications submitted for this PEP. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Type-2 Diabetes Prevention in Women with a Recent History of Gestational Diabetes Mellitus, PEP 2008–R–04.’’ The National Center for Health Marketing determines that agency business requires its consideration of this matter on less than 15 days notice to the public and that no earlier notice of the meeting was possible. Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333, Telephone (404)498– 1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\16JNN1.SGM 16JNN1 34024 Federal Register / Vol. 73, No. 116 / Monday, June 16, 2008 / Notices Dated: June 9, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–13493 Filed 6–13–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services Medicaid Program; Notice of SingleSource Grant Award to the States of Louisiana and Mississippi for the Grant Entitled ‘‘Deficit Reduction ActHurricane Katrina Healthcare Related Provider Stabilization’’ Centers for Medicare & Medicaid Services (CMS). ACTION: Notice of Single-Source NonCompetitive Supplemental Awards. AGENCY: rwilkins on PROD1PC63 with NOTICES Funding Amount: $19,100,000. Period of Performance: June 9, 2008– September 30, 2009. CFDA: 93.776. Authority: Section 6201(a)(4) of the Deficit Reduction Act of 2005 (DRA) Purpose: The Secretary has authorized an additional $19.1 million in supplemental grant funds to be made available to the States of Louisiana and Mississippi. Based on the share of total Medicare inpatient payments made to each State’s eligible general acute care hospitals and inpatient psychiatric facilities (IPFs) located in the Federal Emergency Management Agency (FEMA) designated counties/parishes in calendar year 2006 (the latest and most complete year of Medicare billing data available to us), funding is being allocated in the following proportions: 53 percent to Louisiana ($10,143,671) and 47 percent to Mississippi ($8,956,329). Since its inception, the Provider Stabilization Grant (PSG) program has been used to fund State payments to general acute care hospitals, skilled nursing facilities, IPFs, and community mental health centers in impacted communities that may face financial pressures because of changing wage rates that are not yet reflected in Medicare prospective payment system (PPS) payment methodologies. For this third round of PSG funding, CMS determined that these supplemental grant funds would be used by the States to make payments to only those Medicare participating inpatient PPS (IPPS) hospitals and IPFs that are currently paid under a Medicare PPS VerDate Aug<31>2005 17:04 Jun 13, 2008 Jkt 214001 and that are the most significantly, negatively impacted (financial or otherwise) related to Hurricane Katrina. Although the States had significant discretion in determining the payment distribution methodology, the methodology had to clearly reflect the basis upon which the State would determine ‘‘negative impact’’ and then how each provider would receive an appropriate share of the funds. Grant funds may not be distributed to IPPS hospitals and IPFs that are not in operation or that are outside of the FEMA Hurricane Katrina designated counties/parishes for individual and public assistance. The States’ payment methodologies were to specify the relevant time periods and any other factors that would be considered in distributing available grant funds according to the principles specified above, and were subject to approval by CMS. The States were also allowed to choose to use a portion of the funds (not to exceed 20% of the grant) to address immediate, unmet, health care infrastructure needs that objective data indicate was caused as a direct result of Hurricane Katrina and or its subsequent flooding. This optional provision was also subject to CMS approval. Under the authority of section 6201(a)(4) of the Deficit Reduction Act of 2005, the Secretary, Department of Health and Human Services, has invoked his authority to restore health care in impacted communities affected by Hurricane Katrina by offering this unique funding opportunity to enable States to make payments to assist general acute care hospitals and IPFs that are paid under a Medicare PPS, with the financial pressures that may result from changing wage rates in those impacted communities. Louisiana and Mississippi are the only States with knowledge and ability to administer a grant designed to affect impacted communities in their own respective States. For the reasons cited above, the Secretary has directed CMS to offer supplemental single-source awards to the States of Louisiana and Mississippi. FOR FURTHER INFORMATION CONTACT: Wendy J. Alexander, Ph.D., Health Insurance Specialist, Finance Systems and Budget Group, Centers for Medicaid and State Operations, Centers for Medicare & Medicaid Services, Mail Stop S3–13–15, 7500 Security Boulevard, Baltimore, MD 21244, (410) 786–5245. Authority: Section 6201(a)(4) of the Deficit Reduction Act of 2005 (DRA). PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Dated: June 10, 2008. Kerry Weems, Acting Administrator, Centers for Medicare & Medicaid Services. [FR Doc. E8–13525 Filed 6–13–08; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2008–N–0132] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; State Petitions for Exemption From Preemption AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by July 16, 2008. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202–395–6974, or e-mailed to baguilar@omb.eop.gov. All comments should be identified with the OMB control number 0910–0277. Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of the Chief Information Officer (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827– 4659. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. State Petitions for Exemption From Preemption—21 CFR 100.1(d) (OMB Control No. 0910–0277)—Extension Under section 403A(b) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 343–1(b)), States may petition FDA for exemption from Federal preemption of State food labeling and standard of identity requirements. E:\FR\FM\16JNN1.SGM 16JNN1

Agencies

[Federal Register Volume 73, Number 116 (Monday, June 16, 2008)]
[Notices]
[Pages 34023-34024]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Type-2 Diabetes Prevention in Women with a Recent 
History of Gestational Diabetes Mellitus, Potential Extramural Project 
(PEP) 2008-R-04

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 1 p.m.-4 p.m., June 18, 2008 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463. This notice 
was published in the Federal Register on April 17, 2008, Volume 73, 
Number 75, page 20927. Additional time is required to complete the 
review of all applications submitted for this PEP.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Type-2 Diabetes Prevention in Women 
with a Recent History of Gestational Diabetes Mellitus, PEP 2008-R-
04.''
    The National Center for Health Marketing determines that agency 
business requires its consideration of this matter on less than 15 
days notice to the public and that no earlier notice of the meeting 
was possible.
    Contact Person for More Information: Linda Shelton, Program 
Specialist, Coordinating Center for Health and Information Service, 
Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, 
Atlanta, GA 30333, Telephone (404)498-1194. The Director, Management 
Analysis and Services Office, has been delegated the authority to 
sign Federal Register notices pertaining to announcements of 
meetings and other committee management activities, for both CDC and 
the Agency for Toxic Substances and Disease Registry.


[[Page 34024]]


    Dated: June 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E8-13493 Filed 6-13-08; 8:45 am]
BILLING CODE 4163-18-P